35 results on '"Riverol, Mario"'
Search Results
2. Magnetic Resonance‐Guided Focused Ultrasound (MRgFUS)‐Thalamotomy for Essential Tremor: Lesion Location and Clinical Outcomes.
- Author
-
Arcadi, Alana, Aviles‐Olmos, Iciar, Gonzalez‐Quarante, Lain Hermes, Gorospe, Arantza, Jiménez‐Huete, Adolfo, de la Corte, Marta Macías, Parras, Olga, Martin‐Bastida, Antonio, Riverol, Mario, Villino, Rafael, Guridi, Jorge, and Rodríguez‐Oroz, Maria C.
- Abstract
Background: Factors predicting clinical outcomes after MR‐guided focused ultrasound (MRgFUS)‐thalamotomy in patients with essential tremor (ET) are not well known. Objective: To examine the clinical outcomes and their relationship with patients' baseline demographic and clinical features and lesion characteristics at 6‐month follow‐up in ET patients. Methods: A total of 127 patients were prospectively evaluated at 1 (n = 122), 3 (n = 102), and 6 months (n = 78) after MRgFUS‐thalamotomy. Magnetic resonance imaging (MRI) was obtained at 6 months (n = 60). Primary outcomes included: (1) change in the Clinical Rating Scale of Tremor (CRST)‐A+B score in the treated hand and (2) frequency and severity of adverse events (AEs) at 6 months. Secondary outcomes included changes in all subitems of the CRST scale in the treated hand, CRST‐C, axial tremor (face, head, voice, tongue), AEs, and correlation of primary outcomes at 6 months with lesion characteristics. Statistical analysis included linear mixed, standard, and logistic regression models. Results: Scores for CRST‐A+B, CRST‐A, CRST‐B in the treated hand, CRST‐C, and axial tremor were improved at each evaluation (P < 0.001). Five patients had severe AEs at 1 month that became mild throughout the follow‐up. Mild AEs occurred in 71%, 45%, and 34% of patients at 1, 3, and 6 months, respectively. Lesion volume was associated with the reduction in the CRST‐A (P = 0.003) and its overlapping with the ventralis intermedius nucleus (Vim) nucleus with the reduction in CRST‐A+B (P = 0.02) and CRST‐B (P = 0.008) at 6 months. Conclusions: MRgFUS‐thalamotomy improves hand and axial tremor in ET patients. Transient and mild AEs are frequent. Lesion volume and location are associated with tremor reduction. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. The impact of amyloid‐PET and FDG‐PET on the progression from amnestic MCI to AD dementia in clinical practice.
- Author
-
Echeveste, Beatriz, Arbizu, Javier, Guillén, Fernando, and Riverol, Mario
- Published
- 2023
- Full Text
- View/download PDF
4. Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
- Author
-
Dolcet-Negre, Marta M., Imaz Aguayo, Laura, García-de-Eulate, Reyes, Martí-Andrés, Gloria, Fernández-Matarrubia, Marta, Domínguez, Pablo, Fernández-Seara, Maria A., and Riverol, Mario
- Subjects
MILD cognitive impairment ,ALZHEIMER'S disease ,COGNITION disorders ,MACHINE learning ,MEDIAN (Mathematics) ,GERIATRIC Depression Scale - Abstract
Background: Subjective cognitive decline (SCD) may represent a preclinical stage of Alzheimer's disease (AD). Predicting progression of SCD patients is of great importance in AD-related research but remains a challenge. Objective: To develop and implement an ensemble machine learning (ML) algorithm to identify SCD subjects at risk of conversion to mild cognitive impairment (MCI) or AD. Methods: Ninety-nine SCD patients were included. Thirty-two progressed to MCI/AD, while 67 remained stable. To minimize the effect of class imbalance, both classes were balanced, and sensitivity was taken as evaluation metric. Bagging and boosting ML models were developed by using socio-demographic and clinical information, Mini-Mental State Examination and Geriatric Depression Scale (GDS) scores (feature-set 1a); socio-demographic characteristics and neuropsychological tests scores (feature-set 1b) and regional magnetic resonance imaging grey matter volumes (feature-set 2). The most relevant variables were combined to find the best model. Results: Good prediction performances were obtained with feature-sets 1a and 2. The most relevant variables (variable importance exceeding 20%) were: Age, GDS, and grey matter volumes measured in four cortical regions of interests. Their combination provided the optimal classification performance (highest sensitivity and specificity) ensemble ML model, Extreme Gradient Boosting with over-sampling of the minority class, with performance metrics: sensitivity = 1.00, specificity = 0.92 and area-under-the-curve = 0.96. The median values based on fifty random train/test splits were sensitivity = 0.83 (interquartile range (IQR) = 0.17), specificity = 0.77 (IQR = 0.23) and area-under-the-curve = 0.75 (IQR = 0.11). Conclusion: A high-performance algorithm that could be translatable into practice was able to predict SCD conversion to MCI/AD by using only six predictive variables. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease.
- Author
-
Villarejo-Galende, Alberto, García-Arcelay, Elena, Piñol-Ripoll, Gerard, del Olmo-Rodríguez, Antonio, Viñuela, Félix, Boada, Mercè, Franco-Macías, Emilio, Ibañez de la Peña, Almudena, Riverol, Mario, Puig-Pijoan, Albert, Abizanda-Soler, Pedro, Arroyo, Rafael, Baquero-Toledo, Miquel, Feria-Vilar, Inmaculada, Balasa, Mircea, Berbel, Ángel, Rodríguez-Rodríguez, Eloy, Vieira-Campos, Alba, García-Ribas, Guillermo, and Rodrigo-Herrero, Silvia
- Subjects
ALZHEIMER'S disease ,QUALITY of life ,ALZHEIMER'S patients ,MINI-Mental State Examination ,DISEASE duration ,MILD cognitive impairment ,SELF-evaluation ,EVALUATION research ,RESEARCH ,RESEARCH methodology ,COMPARATIVE studies - Abstract
Background: There is a need to better understand the experience of patients living with Alzheimer's disease (AD) in the early stages.Objective: The aim of the study was to evaluate the perception of quality of life in patients with early-stage AD.Methods: A multicenter, non-interventional study was conducted including patients of 50-90 years of age with prodromal or mild AD, a Mini-Mental State Examination (MMSE) score ≥22, and a Clinical Dementia Rating-Global score (CDR-GS) of 0.5.-1.0. The Quality of Life in Alzheimer 's Disease (QoL-AD) questionnaire was used to assess health-related quality of life. A battery of self-report instruments was used to evaluate different psychological and behavioral domains. Associations between the QoL-AD and other outcome measures were analyzed using Spearman's rank correlations.Results: A total of 149 patients were included. Mean age (SD) was 72.3 (7.0) years and mean disease duration was 1.4 (1.8) years. Mean MMSE score was 24.6 (2.1). The mean QoL-AD score was 37.9 (4.5). Eighty-three percent (n = 124) of patients had moderate-to-severe hopelessness, 22.1% (n = 33) had depressive symptoms, and 36.9% (n = 55) felt stigmatized. The quality of life showed a significant positive correlation with self-efficacy and negative correlations with depression, emotional and practical consequences, stigma, and hopelessness.Conclusion: Stigma, depressive symptoms, and hopelessness are frequent scenarios in AD negatively impacting quality of life, even in a population with short disease duration and minimal cognitive impairment. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
6. Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain.
- Author
-
Villarejo-Galende, Alberto, García-Arcelay, Elena, Piñol-Ripoll, Gerard, del Olmo-Rodríguez, Antonio, Viñuela, Félix, Boada, Mercè, Franco-Macías, Emilio, de la Peña, Almudena Ibañez, Riverol, Mario, Puig-Pijoan, Albert, Abizanda-Soler, Pedro, Arroyo, Rafael, Baquero-Toledo, Miquel, Feria-Vilar, Inmaculada, Balasa, Mircea, Berbel, Ángel, Rodríguez-Rodríguez, Eloy, Vieira-Campos, Alba, García-Ribas, Guillermo, and Rodrigo-Herrero, Silvia
- Subjects
ALZHEIMER'S disease ,LIFE satisfaction ,SCIENTIFIC observation ,AWARENESS ,MILD cognitive impairment - Abstract
Introduction: Limited information is available on people's experiences of living with Alzheimer's disease (AD) at earlier stages. This study assessed awareness of diagnosis among people with early-stage AD and its impact on different person-centered outcome measures. Methods: We conducted an observational, cross-sectional study in 21 memory clinics in Spain. Persons aged 50–90 years, diagnosed with prodromal or mild AD (NIA/AA criteria), a Mini Mental State Examination (MMSE) score ≥ 22, and a Clinical Dementia Rating-Global score (CDR-GS) of 0.5 or 1.0 were recruited. The Representations and Adjustment to Dementia Index (RADIX) was used to assess participants' beliefs about their condition and its consequences. Results: A total of 149 persons with early-stage AD were studied. Mean (SD) age was 72.3 (7.0) years and 50.3% were female. Mean duration of AD was 1.4 (1.8) years. Mean MMSE score was 24.6 (2.1) and 87.2% had a CDR-GS score of 0.5. Most participants (n = 84, 57.5%) used a descriptive term related to specific AD symptoms (e.g., memory difficulties) when asked what they called their condition. Participants aware of their diagnosis using the term AD (n = 66, 45.2%) were younger, had more depressive symptoms, and poorer life satisfaction and quality of life compared to those without awareness of their specific diagnosis. Practical and emotional consequences RADIX scores showed a significant negative correlation with Quality of Life in Alzheimer's Disease score (rho = − 0.389 and − 0.413, respectively; p < 0.0001). Years of education was the only predictor of awareness of AD diagnosis [OR = 1.04 (95% CI 1.00–1.08); p = 0.029]. Conclusions: Awareness of diagnosis was a common phenomenon in persons with early-stage AD negatively impacting their quality of life. Understanding illness representations in earlier stages may facilitate implementing optimized care that supports improved quality of life and well-being. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Grey matter changes on brain MRI in subjective cognitive decline: a systematic review.
- Author
-
Arrondo, Pablo, Elía-Zudaire, Óscar, Martí-Andrés, Gloria, Fernández-Seara, María A., and Riverol, Mario
- Subjects
COGNITION disorders ,VOXEL-based morphometry ,MAGNETIC resonance imaging ,ENTORHINAL cortex ,NEUROPSYCHOLOGICAL tests - Abstract
Introduction: People with subjective cognitive decline (SCD) report cognitive deterioration. However, their performance in neuropsychological evaluation falls within the normal range. The present study aims to analyse whether structural magnetic resonance imaging (MRI) reveals grey matter changes in the SCD population compared with healthy normal controls (HC). Methods: Parallel systematic searches in PubMed and Web of Science databases were conducted, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Quality assessment was completed using the Newcastle-Ottawa Scale (NOS). Results: Fifty-one MRI studies were included. Thirty-five studies used a region of interest (ROI) analysis, 15 used a voxel-based morphometry (VBM) analysis and 10 studies used a cortical thickness (CTh) analysis. Ten studies combined both, VBM or CTh analysis with ROI analysis. Conclusions: Medial temporal structures, like the hippocampus or the entorhinal cortex (EC), seemed to present grey matter reduction in SCD compared with HC, but the samples and results are heterogeneous. Larger sample sizes could help to better determine if these grey matter changes are consistent in SCD subjects. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Psychosocial Adjustment to Illness Scale in family caregivers of patients with Parkinson's Disease: Spanish validation study.
- Author
-
Ambrosio, Leire, Navarta‐Sánchez, Mª Victoria, Portillo, Mª Carmen, Martin‐Lanas, Raquel, Recio, Miriam, and Riverol, Mario
- Subjects
RELIABILITY (Personality trait) ,CAREGIVERS ,RESEARCH evaluation ,PSYCHOLOGICAL adjustment testing ,RESEARCH methodology evaluation ,CROSS-sectional method ,RESEARCH methodology ,DISEASES ,HEALTH surveys ,PSYCHOMETRICS ,MULTITRAIT multimethod techniques ,PARKINSON'S disease ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,CHI-squared test - Abstract
Psychosocial adjustment to a complex and disabling long‐term condition like Parkinson´s disease is a complex, dynamic, cyclical and interactive process. Family caregivers, face multiple challenges that require a significant effort in terms of psychosocial adjustment, which must be considered by healthcare professionals in order to provide a holistic care. The patients' self‐report version of the Psychosocial Adjustment to Illness Scale (PAIS‐SR), which has been validated in Spain for use in Parkinson's disease, is designed to evaluate the psychosocial adjustment of patients. Our purpose was to validate the Spanish PAIS‐SR version for caregivers of patients with Parkinson's disease. An open, national cross‐sectional study with one point‐in‐time evaluation and retest was carried out in 450 family caregivers of patients with Parkinson's disease. Data were collected in Spain from April 2016 to September 2017. The psychometric analysis performed showed that the Spanish version of the PAIS‐SR for caregivers presents adequate indicators of reliability, internal and external validity, and is structured according to the seven‐domain model proposed by the author of the instrument. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
- Author
-
Martinez-Valbuena, Ivan, Valenti-Azcarate, Rafael, Amat-Villegas, Irene, Marcilla, Irene, Marti-Andres, Gloria, Caballero, Maria-Cristina, Riverol, Mario, Tuñon, María-Teresa, Fraser, Paul E., and Luquin, María-Rosario
- Subjects
PRION diseases ,PANCREAS ,NEURODEGENERATION ,PREDIABETIC state ,PROTEIN-protein interactions ,ALZHEIMER'S patients - Abstract
Protein misfolding diseases refer to a variety of disorders that develop as a consequence of the misfolding of proteins in various organs. The etiologies of Parkinson's and Alzheimer's disease remain unclear, but it seems that type two diabetes and other prediabetic states could contribute to the appearance of the sporadic forms of these diseases. In addition to amylin deposition, other amyloidogenic proteins implicated in the pathophysiology of neurodegenerative diseases could have important roles in the pathogenesis of this disease. As we have previously demonstrated the presence of α-synuclein deposits in the pancreas of patients with synucleinopathies, as well as tau and Aβ deposits in the pancreatic tissue of Alzheimer's disease patients, we studied the immunoreactivity of amylin, tau and α-synuclein in the pancreas of 138 subjects with neurodegenerative diseases or type two diabetes and assessed whether the pancreatic β-cells of these subjects present cooccurrence of misfolded proteins. Furthermore, we also assessed the pancreatic expression of prion protein (PrP) in these subjects and its interaction, both in the pancreas and brain, with α-synuclein, tau, Aβ and amylin. Our study shows, for the first time, that along with amylin, pancreatic α-synuclein, Aβ, PrP and tau may contribute together to the complex pathophysiology of type two diabetes and in the appearance of insulin resistance in Alzheimer's and Parkinson's disease. Furthermore, we show that the same mixed pathologies that are observed in the brains of patients with neurodegenerative diseases are also present outside the nervous system. Finally, we provide the first histological evidence of an interaction between PrP and Aβ, α-synuclein, amylin or tau in the pancreas and locus coeruleus. These findings will shed more light on the common pathological pathways shared by neurodegenerative diseases and type two diabetes, benefiting the exploration of common therapeutic strategies to prevent or treat these devastating amyloid diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey.
- Author
-
Frederiksen, Kristian S., Nielsen, Thomas R., Appollonio, Ildebrando, Andersen, Birgitte Bo, Riverol, Mario, Boada, Mercè, Ceccaldi, Mathieu, Dubois, Bruno, Engelborghs, Sebastiaan, Frölich, Lutz, Hausner, Lucrezia, Gabelle, Audrey, Gabryelewicz, Tomasz, Grimmer, Timo, Hanseeuw, Bernard, Hort, Jakub, Hugon, Jacques, Jelic, Vesna, Koivisto, Anne, and Kramberger, Milica G.
- Subjects
MILD cognitive impairment ,ALZHEIMER'S disease ,MEDICAL disclosure ,COUNSELING ,SUPPORT groups - Abstract
Objectives: Mild cognitive impairment (MCI) is associated with an increased risk of further cognitive decline, partly depending on demographics and biomarker status. The aim of the present study was to survey the clinical practices of physicians in terms of biomarker counseling, management, and follow‐up in European expert centers diagnosing patients with MCI. Methods: An online email survey was distributed to physicians affiliated with European Alzheimer's disease Consortium centers (Northern Europe: 10 centers; Eastern and Central Europe: 9 centers; and Southern Europe: 15 centers) with questions on attitudes toward biomarkers and biomarker counseling in MCI and dementia. This included postbiomarker counseling and the process of diagnostic disclosure of MCI, as well as treatment and follow‐up in MCI. Results: The response rate for the survey was 80.9% (34 of 42 centers) across 20 countries. A large majority of physicians had access to biomarkers and found them useful. Pre‐ and postbiomarker counseling varied across centers, as did practices for referral to support groups and advice on preventive strategies. Less than half reported discussing driving and advance care planning with patients with MCI. Conclusions: The variability in clinical practices across centers calls for better biomarker counseling and better training to improve communication skills. Future initiatives should address the importance of communicating preventive strategies and advance planning. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria.
- Author
-
Martí‐Andrés, Gloria, Bommel, Liza, Meles, Sanne K., Riverol, Mario, Valentí, Rafael, Kogan, Rosalie V., Renken, Remco J., Gurvits, Vita, Laar, Teus, Pagani, Marco, Prieto, Elena, Luquin, M. Rosario, Leenders, Klaus L., and Arbizu, Javier
- Abstract
It remains unclear whether the supportive imaging features described in the diagnostic criteria for progressive supranuclear palsy (PSP) are suitable for the full clinical spectrum. The aim of the current study was to define and cross‐validate the pattern of glucose metabolism in the brain associated with a diagnosis of different PSP variants. A retrospective multicenter cohort study performed on 73 PSP patients who were referred for a fluorodeoxyglucose positron emission tomography PET scan: PSP–Richardson's syndrome, n = 47; PSP–parkinsonian variant, n = 18; and progressive gait freezing, n = 8. In addition, we included 55 healthy controls and 58 Parkinson's disease (PD) patients. Scans were normalized by global mean activity. We analyzed the regional differences in metabolism between the groups. Moreover, we applied a multivariate analysis to obtain a PSP‐related pattern that was cross‐validated in independent populations at the individual level. Group analysis showed relative hypometabolism in the midbrain, basal ganglia, thalamus, and frontoinsular cortices and hypermetabolism in the cerebellum and sensorimotor cortices in PSP patients compared with healthy controls and PD patients, the latter with more severe involvement in the basal ganglia and occipital cortices. The PSP‐related pattern obtained confirmed the regions described above. At the individual level, the PSP‐related pattern showed optimal diagnostic accuracy to distinguish between PSP and healthy controls (sensitivity, 80.4%; specificity, 96.9%) and between PSP and PD (sensitivity, 80.4%; specificity, 90.7%). Moreover, PSP–Richardson's syndrome and PSP–parkinsonian variant patients showed significantly more PSP‐related pattern expression than PD patients and healthy controls. The glucose metabolism assessed by fluorodeoxyglucose PET is a useful and reproducible supportive diagnostic tool for PSP–Richardson's syndrome and PSP–parkinsonian variant. © 2020 International Parkinson and Movement Disorder Society [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Evaluation of a psychoeducational intervention compared with education in people with Parkinson's disease and their informal caregivers: a quasi‐experimental study.
- Author
-
Navarta‐Sánchez, María Victoria, Ambrosio, Leire, Portillo, Mari Carmen, Ursúa, Maria Eugenia, Senosiain, Juana M., and Riverol, Mario
- Subjects
ADAPTABILITY (Personality) ,PSYCHOLOGICAL adaptation ,ANALYSIS of variance ,CAREGIVERS ,CLINICAL trials ,COMPARATIVE studies ,STATISTICAL correlation ,RESEARCH methodology ,NURSING ,PARKINSON'S disease ,PATIENT education ,PRIMARY health care ,QUALITY of life ,QUESTIONNAIRES ,RESEARCH evaluation ,RESEARCH funding ,SOCIAL adjustment ,SAMPLE size (Statistics) ,PRE-tests & post-tests ,EDUCATIONAL outcomes ,REPEATED measures design ,DATA analysis software ,PSYCHOEDUCATION - Abstract
Aim: To evaluate the effects of a psychoeducational intervention compared with an education programme to strengthen quality of life, psychosocial adjustment, and coping in people with Parkinson's disease and their informal caregivers. Design: A quasi‐experimental study was performed with repeated measures at baseline, after the intervention and 6 months post‐intervention. Methods: The study was carried out at seven primary care centres from 2015‐2017. A total of 140 people with Parkinson's and 127 informal caregivers were allocated to the experimental and the control groups. The experimental group received a 9‐week psychoeducational intervention, whereas the control group received a 5‐week education programme. Repeated measures ANOVA were used to test differences in quality of life, psychosocial adjustment, and coping between the experimental and control groups and over time. Results: Patients and informal caregivers in both the experimental and control groups showed significantly better psychosocial adjustment at the post‐intervention measurement compared with baseline data. We also found significantly greater quality of life in patients and coping skills in caregivers after the end of the interventions in the experimental and control groups. Nevertheless, no significant differences were identified on the outcomes at the 6‐month post‐intervention measurement. Conclusion: The effect of the psychoeducational intervention was not different from the effect of the education programme. The strategies applied in both interventions followed a group approach led by a multidisciplinary team covering information about PD, healthy lifestyles, and social resources. They might be easily sustained in Primary Care to improve care for people with Parkinson's and informal caregivers. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia.
- Author
-
Guillén, Edgar F., Rosales, Juan J., Lisei, Darío, Grisanti, Fabiana, Riverol, Mario, and Arbizu, Javier
- Published
- 2020
- Full Text
- View/download PDF
14. Coupling of cerebral blood flow and functional connectivity is decreased in healthy aging.
- Author
-
Galiano, Alvaro, Mengual, Elisa, García de Eulate, Reyes, Galdeano, Iñigo, Vidorreta, Marta, Recio, Miriam, Riverol, Mario, Zubieta, José L., and Fernández-Seara, María A.
- Abstract
Aging leads to cerebral perfusion and functional connectivity changes that have been assessed using various neuroimaging techniques. In addition, a link between these two parameters has been demonstrated in healthy young adults. In this work, we employed arterial spin labeling (ASL) fMRI to measure global and voxel-wise differences in cerebral blood flow (CBF) and intrinsic connectivity contrast (ICC) in the resting state in a group of cognitively normal elderly subjects and a group of cognitively normal young subjects, in order to assess the effects of aging on CBF-ICC coupling, which had not been previously evaluated. Our results showed age-related global and regional CBF decreases in prefrontal mesial areas, lateral frontal regions, insular cortex, lateral parietal areas, precuneus and occipital regions. Subcortically, perfusion was reduced in the medial thalamus and caudate nucleus. ICC was also found reduced with age in prefrontal cortical areas and insular cortex, affecting key nodes of the default mode and salience networks. Areas of ICC and CBF decrease partially overlapped, however, the CBF reduction was more extensive and encompassed more areas. This dissociation was accompanied by a decrease in CBF-ICC coupling. These results suggest that aging leads to a disruption in the relationship between CBF and intrinsic functional connectivity that could be due to neurovascular dysregulation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Amylin as a potential link between type 2 diabetes and alzheimer disease.
- Author
-
Martinez‐Valbuena, Ivan, Valenti‐Azcarate, Rafael, Amat‐Villegas, Irene, Riverol, Mario, Marcilla, Irene, Andrea, Carlos E., Sánchez‐Arias, Juan Antonio, Mar Carmona‐Abellan, Maria, Marti, Gloria, Erro, Maria‐Elena, Martínez‐Vila, Eduardo, Tuñon, Maria‐Teresa, Luquin, Maria‐Rosario, Martinez-Valbuena, Ivan, Valenti-Azcarate, Rafael, Amat-Villegas, Irene, de Andrea, Carlos E, Sánchez-Arias, Juan Antonio, Del Mar Carmona-Abellan, Maria, and Erro, Maria-Elena
- Subjects
AMYLIN ,TYPE 2 diabetes ,ALZHEIMER'S disease ,CHRONIC traumatic encephalopathy ,TAU proteins ,PREDIABETIC state ,BRAIN metabolism ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,NERVE tissue proteins ,PANCREAS ,PEPTIDES ,RESEARCH ,EVALUATION research ,RETROSPECTIVE studies ,CASE-control method ,PANCREATIC hormones - Abstract
Objective: Alzheimer disease (AD) is the leading cause of dementia, and although its etiology remains unclear, it seems that type 2 diabetes mellitus (T2DM) and other prediabetic states of insulin resistance could contribute to the appearance of sporadic AD. As such, we have assessed whether tau and β-amyloid (Aβ) deposits might be present in pancreatic tissue of subjects with AD, and whether amylin, an amyloidogenic protein deposited in the pancreas of T2DM patients, might accumulate in the brain of AD patients.Methods: We studied pancreatic and brain tissue from 48 individuals with no neuropathological alterations and from 87 subjects diagnosed with AD. We examined Aβ and tau accumulation in the pancreas as well as that of amylin in the brain. Moreover, we performed proximity ligation assays to ascertain whether tau and/or Aβ interact with amylin in either the pancreas or brain of these subjects.Results: Cytoplasmic tau and Aβ protein deposits were detected in pancreatic β cells of subjects with AD as well as in subjects with a normal neuropathological examination but with a history of T2DM and in a small cohort of control subjects without T2DM. Furthermore, we found amylin deposits in the brain of these subjects, providing histological evidence that amylin can interact with Aβ and tau in both the pancreas and hippocampus.Interpretation: The presence of both tau and Aβ inclusions in pancreatic β cells, and of amylin deposits in the brain, provides new evidence of a potential overlap in the mechanisms underlying the pathogenesis of T2DM and AD. ANN NEUROL 2019;86:539-551. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
16. Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.
- Author
-
De Eulate, Reyes García, Goñi, Irene, Galiano, Alvaro, Vidorreta, Marta, Recio, Miriam, Riverol, Mario, Zubieta, José L., Fernández-Sear, María A., and Fernández-Seara, María A
- Subjects
ALZHEIMER'S disease ,CEREBRAL circulation ,MILD cognitive impairment ,MAGNETIC resonance imaging ,PERFUSION ,PATIENTS ,PHYSIOLOGY ,ANALYSIS of variance ,CHI-squared test ,NEUROPSYCHOLOGICAL tests ,MEMORY disorders ,THREE-dimensional imaging ,CONTRAST media - Abstract
There is increasing evidence of a vascular contribution to Alzheimer's disease (AD). In some cases, prior work suggests that chronic brain hypoperfusion could play a prime pathogenic role contributing to the accumulation of amyloid-β,while other studies favor the hypothesis that vascular dysfunction and amyloid pathology are independent, although synergistic, mechanisms contributing to cognitive impairment. Vascular dysfunction can be evaluated by assessing cerebral blood flow impairment. Phase contrast velocity mapping by MRI offers a non-invasive means of quantifying the total inflow of blood to the brain. This quantitative parameter could be a sensitive indicator of vascular disease at early stages of AD. In this work, phase contrast MRI was used to evaluate cerebral hemodynamics in patients with subjective memory complaints, amnestic mild cognitive impairment, and mild to moderate AD, and compare them with control subjects. Results showed that blood flow and velocity were decreased in the patients with cognitive dysfunction and the decrease correlated with the degree of cognitive impairment as assessed by means of neuropsychological tests. Total cerebral blood flow measurements were clearly reduced in AD patients, but more importantly appeared to be sensitive enough to distinguish between healthy subjects and those with mild cognitive impairment. A quantitative measurement of total brain blood flow could potentially predict vascular dysfunction and compromised brain perfusion in early stages of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
17. CO078 - VARIABILIDAD INTER E INTRAOBSERVADOR EN LA EVALUACIÓN DE LOS ESTUDIOS PET AMILOIDE DE CEREBRO.
- Author
-
Echeveste, Beatriz, Antar, Vicky Betech, Guillén, Edgar Fernando, Bronte, Ángela, Bastidas, Juan Fernando, Cuenca, Teresa, Prieto-Azcárate, Elena, Riverol, Mario, and Arbizu, Javier
- Published
- 2023
- Full Text
- View/download PDF
18. Factors influencing psychosocial adjustment and quality of life in Parkinson patients and informal caregivers.
- Author
-
Navarta-Sánchez, María, Senosiain García, Juana, Riverol, Mario, Ursúa Sesma, María, Díaz de Cerio Ayesa, Sara, Anaut Bravo, Sagrario, Caparrós Civera, Neus, Portillo, Mari, Navarta-Sánchez, María Victoria, Senosiain García, Juana M, Ursúa Sesma, María Eugenia, Díaz de Cerio Ayesa, Sara, Caparrós Civera, Neus, and Portillo, Mari Carmen
- Subjects
PARKINSON'S disease patients ,CAREGIVERS ,QUALITY of life ,MEDICAL care ,PSYCHOSOCIAL factors ,PARKINSON'S disease ,PSYCHOLOGY of caregivers ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,SICKNESS Impact Profile ,EVALUATION research ,CROSS-sectional method ,PSYCHOLOGY - Abstract
Objective: The influence that social conditions and personal attitudes may have on the quality of life (QoL) of Parkinson's disease (PD) patients and informal caregivers does not receive enough attention in health care, as a result of it not being clearly identified, especially in informal caregivers. The aim of this study was to provide a comprehensive analysis of psychosocial adjustment and QoL determinants in PD patients and informal caregivers.Methods: Ninety-one PD patients and 83 caregivers participated in the study. Multiple regression analyses were performed including benefit finding, coping, disease severity and socio-demographic factors, in order to determine how these aspects influence the psychosocial adjustment and QoL in PD patients and caregivers.Results: Regression models showed that severity of PD was the main predictor of psychosocial adjustment and QoL in patients. Nevertheless, multiple regression analyses also revealed that coping was a significant predictor of psychosocial adjustment in patients and caregivers. Furthermore, psychosocial adjustment was significantly related to QoL in patients and caregivers. Also, coping and benefit finding were predictors of QoL in caregivers but not in patients.Conclusions: Multidisciplinary interventions aimed at improving PD patients' QoL may have more effective outcomes if education about coping skills, and how these can help towards a positive psychosocial adjustment to illness, were included, and targeted not only at patients, but also at informal caregivers. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
19. Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.
- Author
-
Prieto, Elena, Domínguez-Prado, Inés, Riverol, Mario, Ortega-Cubero, Sara, Ribelles, María, Luquin, María, Castro, Purificación, and Arbizu, Javier
- Subjects
POSITRON emission tomography ,EPIDEMIOLOGY ,PRION diseases ,SLOW virus diseases ,ELECTRONIC collimation - Abstract
Purpose: Clinical diagnosis of human prion diseases can be challenging since symptoms are common to other disorders associated with rapidly progressive dementia. In this context, F-fluorodeoxyglucose (FDG) positron emission tomography (PET) might be a useful complementary tool. The aim of this study was to determine the metabolic pattern in human prion diseases, particularly sporadic Creutzfeldt-Jakob disease (sCJD), the new variant of Creutzfeldt-Jakob disease (vCJD) and fatal familial insomnia (FFI). Methods: We retrospectively studied 17 patients with a definitive, probable or possible prion disease who underwent FDG PET in our institution. Of these patients, 12 were diagnosed as sCJD (9 definitive, 2 probable and 1 possible), 1 was diagnosed as definitive vCJD and 4 were diagnosed as definitive FFI. The hypometabolic pattern of each individual and comparisons across the groups of subjects (control subjects, sCJD and FFI) were evaluated using a voxel-based analysis. Results: The sCJD group exhibited a pattern of hypometabolism that affected both subcortical (bilateral caudate, thalamus) and cortical (frontal cortex) structures, while the FFI group only presented a slight hypometabolism in the thalamus. Individual analysis demonstrated a considerable variability of metabolic patterns among patients, with the thalamus and basal ganglia the most frequently affected areas, combined in some cases with frontal and temporal hypometabolism. Conclusion: Patients with a prion disease exhibit a characteristic pattern of brain metabolism presentation in FDG PET imaging. Consequently, in patients with rapidly progressive cognitive impairment, the detection of these patterns in the FDG PET study could orient the diagnosis to a prion disease. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
20. Cerebral bleed after shunt for normal pressure hydrocephalus with cerebral amyloid angiopathy.
- Author
-
McDade, Eric, Boot, Brendon P., Riverol, Mario, and Lopez, Oscar
- Published
- 2015
- Full Text
- View/download PDF
21. Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals.
- Author
-
Riverol, Mario, Becker, James T., López, Oscar L., Raji, Cyrus A., Thompson, Paul M., Carmichael, Owen T., Gach, H. Michael, Longstreth Jr., William T., Fried, Linda, Tracy, Russell P., Kuller, Lewis H., López, Oscar L, and Longstreth, William T Jr
- Subjects
CEREBRAL arteriovenous malformations ,BRAIN blood-vessel abnormalities ,BRAIN ,RADIOGRAPHY ,BRAIN injuries ,BODY mass index ,PHYSIOLOGY ,ANALYSIS of variance ,CEREBROVASCULAR disease ,DIGITAL image processing ,MAGNETIC resonance imaging ,NEUROPSYCHOLOGICAL tests ,PERIPHERAL vascular diseases ,RESEARCH funding ,LOGISTIC regression analysis ,PREDICTIVE tests ,RETROSPECTIVE studies - Abstract
Cerebral white matter lesions (WMLs) are considered a reflection of cerebral and systemic small vessel disease (SVD), and are associated with reductions in brain volume. Like the brain, the kidney is also sensitive to factors that affect vasculature. Glomerular dysfunction due to renal vascular damage can be measured with different biochemical parameters, such as creatinine or cystatin C, although cystatin C is considered to be more accurate than creatinine in the elderly. The purpose of the study was to determine whether manifestations of SVD in the kidney can predict SVD-based damage to the brain. We examined the relationship between glomerular dysfunction as a measure of SVD on WMLs, gray matter (GM) volume, and cognition in 735 cognitively normal participants from the Cardiovascular Health Study Cognition Study. The multivariate analyses controlled for demographic characteristics, hypertension, heart disease, diabetes, Apolipoprotein 4 allele, C reactive protein, lipids, physical activity, smoking, and body mass index (BMI). Elevated cystatin C levels were associated with lower neuropsychological test scores, the presence of MRI-identified brain infarcts, the severity of WMLs, and GM atrophy five years later. In adjusted models, GM volume was significantly associated with cystatin-C only until BMI and severity of WMLs were added to the model, meaning that the effect of SVD on GM volume is mediated by these two variables. These findings suggest that age-related SVD is a process that leads to altered brain structure, and creates a vulnerability state for cognitive decline. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
22. [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis.
- Author
-
Rosales, Juan J., Toledano, Carlos, Riverol, Mario, and Arbizu, Javier
- Subjects
POSITRON emission tomography ,GLIAL fibrillary acidic protein ,NEUROLOGIC examination - Abstract
Lately, an [18F]-FDG-PET pattern of limbic encephalitis was described in a case of GFAP-astroglial autoimmunity presenting with parkinsonism [[3]]. This article is part of the Topical Collection on Neurology A 54-year-old man with a history of rapidly progressive cognitive decline and movement disability for more than 6 months was referred to our institution with a possible diagnosis of prion disease. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
23. Cephalalgia Alopecia or Nummular Headache With Trophic Changes? A New Case With Prolonged Follow-Up.
- Author
-
Irimia, Pablo, Palma, Jose ‐ Alberto, Idoate, Miguel Angel, España, Agustin, Riverol, Mario, and Martinez ‐ Vila, Eduardo
- Subjects
HEADACHE diagnosis ,BALDNESS ,BOTULINUM toxin ,HEADACHE ,DIAGNOSIS - Abstract
Cephalalgia alopecia is a rare and recently described headache syndrome in which recurrent, burning head and neck pain is associated with hair loss from areas of scalp affected by the pain. We here report the case of a 33-year-old woman with continuous unilateral occipital pain and colocalized alopecia, only responsive to onabotulinumtoxin A injections. We hypothesize whether this clinical phenotype may correspond to either cephalalgia alopecia or nummular headache with trophic changes, conditions that might represent 2 manifestations of the same spectrum of disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
24. Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys.
- Author
-
DiCaudo, Carla, Riverol, Mario, Mundiñano, Iñaki-Carril, Ordoñez, Cristina, Hernández, María, Marcilla, Irene, and Luquin, Maria-Rosario
- Subjects
NEURONS ,NEUROTROPHINS ,TYROSINE hydroxylase ,CELLS ,LABORATORY monkeys ,GLUTAMIC acid - Abstract
In addition to the medium spiny neurons the mammalian striatum contains a small population of GABAergic interneurons that are immunoreactive for tyrosine hydroxylase (TH), which dramatically increases after lesions to the nigrostriatal pathway and striatal delivery of neurotrophic factors. The regulatory effect of levodopa (L-Dopa) on the number and phenotype of these cells is less well understood. Eleven macaques (Macaca fascicularis) were included. Group I (n = 4) received 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and L-Dopa; Group II (n = 4) was treated with MPTP plus vehicle and Group III (n = 3) consist of intact animals (control group). L-Dopa and vehicle were given for 1 year and animals sacrificed 6 months later. Immunohistochemistry against TH was used to identify striatal and nigral dopaminergic cells. Double and triple labeling immunofluorescence was performed to detect the neurochemical characteristics of the striatal TH-ir cells using antibodies against: TH, anti-glutamate decarboxylase (GAD
67 ) anti-calretinin (CR) anti-dopa decarboxylase (DDC) and anti-dopamine and cyclic AMP-regulated phosphoprotein (DARPP-32). The greatest density of TH-ir striatal cells was detected in the striatum of the L-Dopa treated monkeys and particularly in its associative territory. None of the striatal TH-ir cell expressed DARPP-32 indicating they are interneurons. The percentages of TH-ir cells that expressed GAD67 and DDC was approximately 50%. Interestingly, we found that in the L-Dopa group the number of TH/CR expressing cells was significantly reduced. We conclude that chronic L-Dopa administration produced a long-lasting increase in the number of TH-ir cells, even after a washout period of 6 months. L-Dopa also modified the phenotype of these cells with a significant reduction of the TH/CR phenotype in favor of an increased number of TH/GAD cells that do not express CR. We suggest that the increased number of striatal TH-ir cells might be involved in the development of aberrant striatal circuits and the appearance of L-Dopa induced dyskinesias. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
25. Evolution of the diagnostic criteria for degenerative and cognitive disorders.
- Author
-
Lopez, Oscar L, McDade, Eric, Riverol, Mario, and Becker, James T
- Published
- 2011
- Full Text
- View/download PDF
26. Primary Whipple disease of the CNS presenting with chorea and dystonia.
- Author
-
Palma, Jose-Alberto, Luquin, Maria R., Riverol, Mario, Irimia, Pablo, Fernandez-Alonso, Miriam, Tejada, Javier, and Martinez-Vila, Eduardo
- Published
- 2014
- Full Text
- View/download PDF
27. Blood Pressure and Risk of Cognitive Impairment: The Role of Vascular Disease in Neurodegeneration.
- Author
-
Carmona-Abellan, Mar, Trzeciak, Malwina, Fernández, Miriam Recio, Echeveste, Beatriz, Imaz, Laura, Luquin, Maria-Rosario, and Riverol, Mario
- Subjects
BLOOD pressure ,COGNITIVE testing ,COGNITION disorders ,HEART beat ,MILD cognitive impairment ,VASCULAR diseases ,VASCULAR dementia - Abstract
(1) Background: Both cerebral vascular disorders and cognitive decline increase in incidence with age. The role of cerebral vascular disease and hemodynamic changes in the development of cognitive deficits is controversial. The objective of this study was to assess the cardiovascular response during cardiac stress testing in neurologically asymptomatic individuals who developed cognitive impairment several years after previous cardiac stress testing. (2) Methods: This was a retrospective cohort study of patients who underwent cardiac stress testing between January 2001 and December 2010. Patients were followed up until May 2015, and we selected those who developed cognitive dysfunction including dementia, mild cognitive impairment, and subjective cognitive decline, after the stress test. Heart rate and blood pressure both at rest and at peak exercise, and the mean R-R interval at rest were recorded. For each patient who developed cognitive impairment, we selected one matched control who did not show cognitive decline by the end of the follow-up period. (3) Results: From the cohort of 7224 patients, 371 developed cognitive impairment; of these, 186 (124 men) met the inclusion criteria, and 186 of the other patients were selected as matched controls. During follow-up, cognitive impairment appeared 6.2 ± 4.7 years after the cardiac stress test. These patients who had subsequently developed cognitive impairment had significantly lower at-rest systolic, diastolic, and mean blood pressure than controls (p < 0.05). Further, compared with controls, their maximum heart rate was significantly higher at peak exercise. (4) Conclusion: The results from this study suggest that differences in cardiovascular response to stress might be present in individuals who develop cognitive decline. These findings challenge the possibility of assessing blood pressure and heart rate variability at rest and during cardiac stress as potential risk factors associated with cognitive impairment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Paraneoplastic encephalitis presenting as pure word deafness in a patient with small cell lung cancer.
- Author
-
Palma, Jose-Alberto, Lamet, Isabel, Riverol, Mario, and Martínez-Lage, Pablo
- Subjects
WORD deafness ,NEUROPSYCHOLOGICAL tests ,SMOKING ,HEALTH ,PHYSIOLOGICAL aspects of speech ,PARANEOPLASTIC syndromes ,NEUROLOGIC manifestations of general diseases - Abstract
The article focuses on the treatment methodology of pure word deafness (PWD) which is a neuropsychologic syndrome characterized by the inability to repeat speech or comprehend it. It also discusses the medical condition of 52 year old with a history of smoking and he was presented for the eruption of difficulties in understanding spoken languages. The patient was diagnosed by paraneoplastic neurological syndrome.
- Published
- 2012
- Full Text
- View/download PDF
29. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results.
- Author
-
Moreno-Ajona, David, Prieto, Elena, Grisanti, Fabiana, Esparragosa, Inés, Sánchez Orduz, Lizeth, Gállego Pérez-Larraya, Jaime, Arbizu, Javier, and Riverol, Mario
- Subjects
ANTI-NMDA receptor encephalitis ,IMAGE analysis ,ENCEPHALITIS ,POSITRON emission tomography ,CEREBROSPINAL fluid ,MAGNETIC resonance imaging - Abstract
Brain positron emission tomography imaging with 18Fluorine-fluorodeoxyglucose (FDG-PET) has demonstrated utility in suspected autoimmune encephalitis. Visual and/or assisted image reading is not well established to evaluate hypometabolism/hypermetabolism. We retrospectively evaluated patients with autoimmune encephalitis between 2003 and 2018. Patients underwent EEG, brain magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) sampling and autoantibodies testing. Individual FDG-PET images were evaluated by standard visual reading and assisted by voxel-based analyses, compared to a normal database. For the latter, three different methods were performed: two based on statistical surface projections (Siemens syngo.via Database Comparison, and 3D-SSP Neurostat) and one based on statistical parametric mapping (SPM12). Hypometabolic and hypermetabolic findings were grouped to identify specific patterns. We found six cases with definite diagnosis of autoimmune encephalitis. Two cases had anti-LGI1, one had anti-NMDA-R and two anti-CASPR2 antibodies, and one was seronegative.
18 F-FDG-PET metabolic abnormalities were present in all cases, regardless of the method of analysis. Medial–temporal and extra-limbic hypermetabolism were more clearly depicted by voxel-based analyses. We found autoantibody-specific patterns in line with the literature. Statistical surface projection (SSP) methods (Neurostat and syngo.via Database Comparison) were more sensitive and localized larger hypermetabolic areas. As it may lead to comparable and accurate results, visual analysis of FDG-PET studies for the diagnosis of autoimmune encephalitis benefits from voxel-based analysis, beyond the approach based on MRI, CSF sample and EEG. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
30. P1‐376: ARE NEUROIMAGING BIOMARKERS USEFUL TO DIAGNOSE PRODROMAL AD IN CLINICAL PRACTICE? EXPERIENCE AT A TERTIARY CLINIC.
- Author
-
Echeveste, Beatriz, Recio, Miriam, Imaz, Laura, Garcia de Eulate, Reyes, Arbizu, Javier, and Riverol, Mario
- Published
- 2018
- Full Text
- View/download PDF
31. Variant Creutzfeldt-Jakob disease occurring in mother and son.
- Author
-
Riverol M, Palma JA, Alañá M, Guerrero-Márquez C, Luquin MR, Rábano A, Riverol, Mario, Palma, Jose-Alberto, Alañá, Mónica, Guerrero-Márquez, Carmen, Luquin, María Rosario, and Rábano, Alberto
- Published
- 2012
- Full Text
- View/download PDF
32. Variant Creutzfeldt--Jakob disease occurring in mother and son.
- Author
-
Riverol, Mario, Palma, Jose-Alberto, Alañá, Mónica, Guerrero-Márquez, Carmen, Luquin, María Rosario, and Rábano, Alberto
- Subjects
CREUTZFELDT-Jakob disease ,BOVINE spongiform encephalopathy ,ELECTROENCEPHALOGRAPHY ,CEREBROSPINAL fluid ,PRION diseases ,PROTEINS - Abstract
The article describes the case of a mother and son who both developed variant Creutzfeldt-Jakob disease (vCJD). vCJD has certain characteristics that distinguish it from sporadic CJD. These include a causal association with bovine spongiform encephalopathy (BSE) prions mainly through ingestion, lower sensitivity for 14-3-3 protein in cerebrospinal fluid (CSF), absence of triphasic periodic Electroencephalography (EEG), and death at younger age.
- Published
- 2012
- Full Text
- View/download PDF
33. Intracranial extramedullary hematopoiesis associated with multiple myeloma.
- Author
-
Palma, Jose-Alberto, Dominguez, Pablo D, and Riverol, Mario
- Published
- 2013
- Full Text
- View/download PDF
34. Intracranial extramedullary hematopoiesis associated with multiple myeloma.
- Author
-
Palma, Jose-Alberto, Dominguez, Pablo D., and Riverol, Mario
- Published
- 2013
- Full Text
- View/download PDF
35. Does basal forebrain atrophy mediate or moderate the effect of hippocampal atrophy on the risk for mild cognitive impairment?
- Author
-
Becker, James T. and Riverol, Mario
- Subjects
PROSENCEPHALON ,ATROPHY ,COGNITION disorders ,MEMORY ,HIPPOCAMPUS (Brain) - Abstract
The article examines whether basal forebrain atrophy mediates or moderates the effect of hippocampal atrophy on the risk for mild cognitive impairment. According to the author, the hippocampus has had a significant role in the understanding of memory and is an ideal field for research since it is easily identified, anatomically well organised, and has well defined intra- and inter-regional connections. The author notes that small variations in spatial alignment in analysis have an impact on the ability to detect change in basal forebrain (BFA) volume.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.